Department of Paediatric Hematology and Oncology, The National Oncology Centre.
Paediatric Infectious Disease, Department of Child Health.
J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e975-e978. doi: 10.1097/MPH.0000000000002061.
In March 2020, WHO announced Coronavirus Disease 2019 (COVID-19) outbreak a global pandemic. During this pandemic, patients with sickle cell disease (SCD) have been placed in the "high-risk" category of the population. Although there are numerous publications describing COVID-19 in adult patients, pediatric data are still limited.
Herein, we report case series of 5 sickle cell disease Omani children who got infected with COVID-19; illustrating their different ways of presentation, management and highlighting the outcomes.
Although SCD patients are considered as a high-risk group, all of the observed patients, and whose cases are reported here, have recovered. A large scale of SCD cases should be studied to reach more conclusive results.
2020 年 3 月,世界卫生组织宣布 2019 年冠状病毒病(COVID-19)疫情为全球大流行。在此期间,镰状细胞病(SCD)患者被置于人群的“高风险”类别。虽然有许多出版物描述了成年患者的 COVID-19,但儿科数据仍然有限。
在这里,我们报告了 5 例感染 COVID-19 的阿曼镰状细胞病儿童的病例系列,说明了他们不同的表现方式、管理方式,并强调了结果。
虽然 SCD 患者被认为是高风险群体,但所有观察到的患者,包括本文报告的病例,都已康复。应该对大规模的 SCD 病例进行研究,以得出更具结论性的结果。